MannKind Corporation
NASDAQMannKind Corporation heads into the final week of August with shorts rebuilding at the margin, institutions adding aggressively, and analysts pointing to a stock that trades at less than half its consensus target — a gap that has persisted all year without closing. Short interest has quietly climbed over the past month. Bears hold roughly 9.8% of the free float, up about 7% from 30…
Snapshot as of 20 Sept 2026
MannKind Corporation heads into the final week of August with shorts rebuilding at the margin, institutions adding aggressively, and analysts pointing to a stock that trades at less than half its consensus target — a…
MannKind Corporation has had the most explosive week in its recent history — up 19% in five sessions to $3.53 — and the bears are on the wrong side of it. Short interest has been creeping higher this week even as the…
MannKind Corporation heads into its May 8 Q1 earnings call with call buyers firmly in charge — and a stock that has just retraced nearly half of a devastating post-earnings collapse in under six weeks. The options…
MNKD reports Q1 2026 results on the same day it announced a new dry powder inhalation program for Ralinepag — a partnership with United Therapeutics — giving the stock two live catalysts to absorb at once. The options…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MNKD — free to start on ORTEX.
Sign up for free →Open MNKD on ORTEX